340B Background and Trends
Increases in Part B Drug Utilization at Enrolling 340B Hospitals December 2018
Measuring the Relative Size of the 340B Program: 2017 Update July 2018
Review of the 340B Drug Pricing Program January 2018
Measuring the Relative Size of the 340B Program: 2012–2017 July 2017
COA: The 340B Drug Discount Program in Review: A Look at the Data and Evidence to Date April 2017
Fact Sheet on Distribution of Physician Administered Drugs in 340B February 2016
340B Program Sales Forecast: 2016-2021 December 2016
Growth of the 340B Program: Past Trends, Future Projections November 2014
Primer: Understanding the 340B Drug Pricing Program June 2014
Unprecedented Growth, Questionable Policy: The 340B Drug Program Winter 2014
The Impact of Growth in 340B Contract Pharmacy Arrangements Summer 2014
340B Hospitals
Compliance Trends with Hospital Charity Care Requirements April 2016
Unfulfilled Expectations: An Analysis of Charity Care Provided in 340B Hospitals Spring 2014
GAO/OIG Reports
GAO Report: Increased Oversight Needed to Ensure Nongovernmental Hospitals Meet Eligibility Requirements January 2020
GAO Report: Characteristics of Hospitals Participating and Not Participating in the 340B Program July 2018
GAO Report: Federal Oversight of Compliance at 340B Contract Pharmacies Needs Improvement June 2018
GAO Report: Update on Agency Efforts to Improve 340B Program Oversight July 2017
GAO Report: Manufacturer Discounts in the 340B Program Offer Benefits, But Federal Oversight Needs Improvement September 2011
OIG Report: Contract Pharmacy Arrangements in the 340B Program February 2014
Physician Practices
Hospital Acquisitions of Physician Practices and the 340B Program June 2015
340B Covered Entity Acquisitions of Physician-based Oncology Practices April 2014
Medicare
Impact on Medicare Payments of Shift in Site of Care for Chemotherapy Administration June 2014
Innovations in Cancer Care and Implications for Health Systems May 2014